Methyl 3-(4-methoxyphenyl)propiolate, 95.0%, 250mg

Monocarbinol terminated polydimethylsiloxane, asymmetric, 80-90cSt, 97%, 100g

2-Methyl-2-phenylpropanal, 97%, 5g

5-CYCLOPROPYL-N-METHYL-1,3,4-THIADIAZOL-2-AMINE, 95.0%, 100mg

N-(3-hydroxyazetidin-1-yl)(tert-butoxy)formamide, 95.0%, 10g

N-[4-(7-Methoxyquinolin-4-yl)benzyl]sulfamide, 98.0%, 50mg

ERIODICTYOL, 99%, 25mg

4-Hydroxycyclohexanecarbonitrile, 95.0%, 500mg

2,3-Dihydrobenzo[d]isothiazole 1,1-dioxide, 95.0%, 250mg

(2R,3R,4S,5R)-2-(6-((3-Hydroxybenzyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 97.0%, 250mg

Bis[4-(hexyloxy)phenyl]amine>98.0%(GC)(T)5g

Methyl 1-chloroisoquinoline-3-carboxylate, 95%, 250mg

4-Bromo-2,6-diiodophenol, 97%, 1g